Association of genetic variation of the six gene prognostic model for castration-resistant prostate cancer with survival

The Prostate
Wanling XiePhilip W Kantoff

Abstract

We previously identified a blood RNA transcript-based model consisting of six immune or inflammatory response genes (ABL2, SEMA4D, ITGAL, C1QA, TIMP1, and CDKN1A) that was prognostic for survival in cohorts of men with castration-resistant prostate cancer (CRPC). We investigated whether inherited variation in these six genes was associated with overall survival (OS) in men with CRPC. The test cohort comprised 600 patients diagnosed with CRPC between 1996 and 2011 at Dana-Farber Cancer Institute. Genotyping of 66 tagging single nucleotide polymorphisms (SNPs) spanning the six genes was performed on blood derived DNAs. For the top four SNPs (P < 0.05), validation was conducted in an independent cohort of 223 men diagnosed with CRPC between 2000 and 2014. Multivariable Cox regression adjusting for known prognostic factors estimated hazard ratios (HR) and 95% confidence intervals (CI) of the association of genetic variants with OS. Two thirds of patients in both cohorts had metastases at CRPC diagnosis. Median OS from CRPC diagnosis was 3.6 (95%CI 3.3-4.0) years in the test cohort and 4.6 (95%CI 3.8-5.2) years in the validation cohort. Fifty-nine SNPs in Hardy-Weinberg equilibrium were analyzed. The major alleles of rs1318056 and r...Continue Reading

References

Apr 1, 1993·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·W K KellyS D Fossa
Mar 20, 2002·Nature Reviews. Cancer·B J Feldman, D Feldman
Sep 28, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Oren SmaletzMichael W Kattan
Mar 29, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Susan HalabiNicholas J Vogelzang
Jul 25, 2003·The New England Journal of Medicine·William G NelsonWilliam B Isaacs
Jul 29, 2003·Proceedings of the National Academy of Sciences of the United States of America·John D Storey, Robert Tibshirani
Nov 6, 2003·Journal of Cell Science·Nancy HoggAlison McDowall
Apr 15, 2004·Endocrine Reviews·Cynthia A Heinlein, Chawnshang Chang
Jul 23, 2004·Current Biology : CB·Patricia A ZipfelAnn Marie Pendergast
Jul 19, 2005·Immunology Letters·Patrick TerheydenMarcus Kaul
Mar 7, 2006·Pharmacogenomics·Michael E Burczynski, Andrew J Dorner
Apr 19, 2006·Journal of Cellular Biochemistry·Irina U Agoulnik, Nancy L Weigel
May 9, 2006·Cancer Metastasis Reviews·Rosemarie ChircoHyeong-Reh Choi Kim
Jul 25, 2006·Clinical Genitourinary Cancer·William K OhJane Weeks
Jun 5, 2007·Immunobiology·Jinhua LuBoon King Teh
Jul 13, 2007·Immunological Reviews·Andrew SmithNancy Hogg
Mar 6, 2008·Cellular & Molecular Immunology·Jin Hua LuKenneth B M Reid
Jun 19, 2008·The Journal of Experimental Medicine·Jose Rafael SierraSilvia Giordano
May 5, 2009·Nature Reviews. Rheumatology·Jason W BauerEmily C Baechler
May 19, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Ricardo M AttarMarco M Gottardis
Aug 24, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Howard I ScherGlenn Heller
Feb 14, 2012·Current Opinion in Oncology·Eric G Bluemn, Peter S Nelson
Oct 20, 2012·Current Opinion in Organ Transplantation·Silke RoedderMinnie M Sarwal
Jan 6, 2016·Journal of Cell Science·Aaditya KhatriAnn Marie Pendergast

❮ Previous
Next ❯

Citations

Dec 19, 2020·Open Medicine·Chen JiZhongqin Cheng

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.